TNFRSF11B is associated with advanced lymph node metastasis and poorer survival outcomes in colon cancer patients, potentially by inhibiting memory-activated CD4+ T cell infiltration (Zhang et al., 2021). This evidence concerns the gene TNFRSF11B and metastatic malignant neoplasm in the lymph nodes.